ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office

January 24, 2024

https://www.globenewswire.com/news-release/2024/01/24/2815309/0/en/ELEVAI-Labs-Inc-Announces-Issuance-of-Patent-from-U-S-Patent-Trademark-Office.html

NEWPORT BEACH, Calif., Jan. 24, 2024 (GLOBE NEWSWIRE) — ELEVAI LABS, INC., (NASDAQ:ELAB) a medical aesthetic company specializing in physician-dispensed skincare, is pleased to announce today that the United States Patent & Trademark Office (USPTO) issued US Patent No. 11,878,038, entitled “Exosome-based Skincare Product” (the “Patent”) covering the primary formulation for ELEVAI’s exosome-based skin care products. The ELEVAI exosomes™ used in ELEVAI Labs’ formulations are derived from specially cultured and treated umbilical mesenchymal stem cells to generate a specific profile for the applications desired. ELEVAI’s enfinity™ and empower™ formulations are both covered by the Patent.

Read more at globenewswire.com

Related news for (ELAB)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.